Besides these systemic/nosocomial factors, there is a growing speculation that overexpression of SARS‐CoV‐2 cellular entry proteins might contribute to amplify the risk of viral attachment in lung cancer lesions (Kong et al., 2020). Here, PROS1 is linked to lung cancer.